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Background: The majority of prognostic studies on the use of B-type natriuretic peptide (BNP) testing has focused on single-point measurement 
with implications on serial testing, but the incremental prognostic information on serial BNP testing has not been validated.
Methods: We evaluated 758 consecutive ambulatory patients with chronic heart failure who had at least six consecutive BNP measures (>3 
months apart) in 2001-7 in order to determine the impact of their changes over time on mortality risk (censored transplant).
Results: In our study cohort (mean age 69 ±15 years, 65% male, 72% Caucasian, LVEF 31% ±16, and baseline Cr 1.2 ± 0.7), median baseline 
BNP was 442 pg/mL (interquartile range 214-902 pg/mL), with an average of 3.3±1.3 years follow-up. Baseline LVEF, blood urea nitrogen, and 
hemoglobin were independent predictors of elevated baseline BNP levels after adjusting for age, gender, serum creatinine, and lipid profile. At cut-off 
of 400 pg/mL, high baseline BNP portends poorer prognosis (Hazard ratio 1.67, 95%CI 1.26-2.29, p<0.01). A step-wise increase in mortality risk 
was observed from BNP patterns over time: persistently Low (400 to <400 pg/mL), from Low-to-High (from 400 pg/mL), and persistently High (>400 
pg/mL, see Figure).
Conclusions: In a large cohort of ambulatory patients with serial BNP testing, changes in BNP levels over time were powerful predictors of survival.
